Global Blood Therapeutics (United States)
- Research works
- 58 ▲ 125% vs 2013–17
- Citations
- 776 13.5 per fractional work
- Top-10% rate
- 5.4% record average 16.5%
- Open access
- 50% world 28%
Not ranked overall: Global Blood Therapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 4.5×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 4.5×
- Medicine 3.5×
- Biochemistry, Genetics and Molecular Biology 3.0×
- Immunology and Microbiology 2.4×
- Health Professions 0.9×
- Neuroscience 0.5×
- Economics, Econometrics and Finance 0.5×
- Agricultural and Biological Sciences 0.3×
- Computer Science 0.3×
- Social Sciences 0.3×
- Environmental Science 0.2×
- Business, Management and Accounting 0.1×
Which keywords describe research at Global Blood Therapeutics (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Sickle-cell Disease, Thalassemia, Erythropoiesis, Anemia, Oxidative Stress, Inflammation and Iron Deficiency.
- Treatment
- Newborn Screening
- Management
- Homocysteine
- Biomarkers
- Cardiovascular Disease
- Alloimmunization
- Hemoglobin
- Piezo1
- Iron Regulation
- Iron Deficiency
- Oxidative Stress
- Erythropoiesis
- Sickle-cell Disease
- Epidemiology
- Thalassemia
- Anemia
- Inflammation
- Hepcidin
- Apoptosis
- Piezo2
- Scavenger Receptor
- Blood Groups
- Endothelial Dysfunction
- Folate
- Neuroprotection
- Cell-Free DNA
- Thrombosis
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 28 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 28 words, with their numbers
- Epidemiology14▲ 6.0×14 topics
- Sickle-cell Disease12▲ 440×1 topic
- Thalassemia12▲ 440×1 topic
- Erythropoiesis10▲ 200×2 topics
- Anemia9▲ 137×3 topics
- Oxidative Stress8▲ 7.5×7 topics
- Inflammation8▲ 5.7×6 topics
- Iron Deficiency6▲ 200×2 topics
- Hepcidin6▲ 251×1 topic
- Iron Regulation6▲ 251×1 topic
- Apoptosis4▲ 20×2 topics
- Piezo14▲ 152×1 topic
- Piezo24▲ 152×1 topic
- Hemoglobin4▲ 208×1 topic
- Scavenger Receptor4▲ 208×1 topic
- Alloimmunization2▲ 117×1 topic
- Blood Groups2▲ 117×1 topic
- Cardiovascular Disease2▲ 3.3×5 topics
- Endothelial Dysfunction2▲ 12×3 topics
- Biomarkers1▲ 3.8×6 topics
- Folate1▲ 61×1 topic
- Homocysteine1▲ 61×1 topic
- Neuroprotection1▲ 6.1×3 topics
- Management1▲ 2.8×2 topics
- Cell-Free DNA1▲ 21×2 topics
- Newborn Screening1▲ 17×2 topics
- Thrombosis1▲ 8.6×3 topics
- Treatment1▲ 1.38×4 topics
Which research topics does Global Blood Therapeutics (United States) publish most on?
By volume in 2022–2025: Hemoglobinopathies and Related Disorders, Iron Metabolism and Disorders, Blood groups and transfusion and Erythrocyte Function and Pathophysiology.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Hemoglobinopathies and Related Disorders Genetics 4 works
- 2 Iron Metabolism and Disorders Hematology 2 works
- 3 Blood groups and transfusion Hematology 1 works
- 4 Erythrocyte Function and Pathophysiology Physiology 1 works
- 5 Pediatric Urology and Nephrology Studies Pediatrics, Perinatology and Child Health 0 works
- 6 Hemoglobin structure and function Cell Biology 0 works
- 7 Epigenetics and DNA Methylation Molecular Biology 0 works
- 8 Kidney Stones and Urolithiasis Treatments Pulmonary and Respiratory Medicine 0 works
- 9 Neonatal Health and Biochemistry Pediatrics, Perinatology and Child Health 0 works
- 10 Computational Drug Discovery Methods Computational Theory and Mathematics 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Global Blood Therapeutics (United States)'s research output changed?
Output in 2018–2022 was 125% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in South San Francisco
- Sunesis (United States)
- Exelixis (United States)
- Kaiser Permanente South San Francisco Medical Center
- Cytokinetics (United States)
- Portola Pharmaceuticals (United States)
- NGM Biopharmaceuticals (United States)
- Rapt Therapeutics (United States)
- Atara Biotherapeutics (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.